News item covers ISMP’s alert regarding Paxlovid for treatment of COVID-19, highlighting that a dose reduction is necessary for patients with moderate renal impairment.
For the full text, visit APhA online.
Click to return to the ISMP homepage.
Log in to MyECRI to access your subscriptions and memberships.
REPORT A MEDICATION OR VACCINE ERROR
Your reports help prevent errors and patient harm from reoccurring.
Click to learn about the Institute for Safe Medication Practices.